Florida Dental Convention
Appropriate Chemotherapeutics for the Advanced Periodontal Patient Workshop
Course code: W12
Start time: Thursday, June 27, 2019, 2:00 PM
End time: Thursday, June 27, 2019, 5:00 PM
Room: SANIBEL 2
Recommended Participants: Dentists, Hygienists, Dental Student
CE Hours: 3.00
Track: PERIODONTICS, PHARMACOLOGY
Equipment Sponsor:
Arestin/Orapharma
Dexcel Technologies / PerioChip Inc.
ProBiora Health LLC
Quest Products
Partial Sponsor:
Colgate
Florida Association of Periodontists

Speaker: Dr. Gregory Oxford, DDS, MS, PhD

About the speaker: Dental degree, Emory University; Ph.D. in molecular biology, University of Florida; private practice, St. Augustine, FL.

I nor any members of my immediate family have any financial relationships with any commercial entities that may be relevant during this presentation.

Disclosure: Neither I nor members of my immediate family have any financial relationships with commercial entities that may be relevant to this presentation.

REGISTRATION CATEGORY 

 EARLY 4/5 

 REGULAR 

 ONSITE 6/15 

DENTIST - FDA/ADA MEMBER

$225

$250

$275

NON-MEMBER DENTIST

$250

$275

$300

TEAM MEMBER

$180

$225

$250

DENTAL STUDENT

$180

$225

$250


Description:
Not all patients who need or require surgical periodontal care are candidates for this form of therapy. A variety of factors preclude them from receiving or pursuing surgery to correct their problems. This patient population may benefit from a variety of chemotherapeutic pharmacologic agents currently available to affect host modulation and address their disease. This workshop will explore the rationale and appropriate usage of pharmacologic agents used as adjuncts to traditional modes of periodontal therapy, as well as DNA culturing to assist in the selection of medications. Attendance is limited to 25.

Partial Sponsor: Colgate
Equipment Sponsor: Arestin/Orapharma, Dexcel Technologies / PerioChip Inc., ProBiora Health LLC, Quest Products

Learning objectives:

Participants will be able to:

  • understand the etiology of periodontal disease.
  • identify the patients who can most benefit from adjunctive pharmacotherapeutic medications.
  • determine which medications may be most advantageous for their patients.  



Participant Requirements:
Loupes





Search sessions by day, speaker, track, course type, participants, or display all sessions.







Florida Dental Association
545 John Knox Rd, Ste. 200
Tallahassee FL 32303
800.877.9922

fdc@floridadental.org